Global Sacubitril Valsartan Sodium Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Sacubitril Valsartan Sodium Drugs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sacubitril Valsartan Sodium Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Oral Pellets
1.3 Market Segmentation by Application
1.3.1 Global Sacubitril Valsartan Sodium Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sacubitril Valsartan Sodium Drugs Revenue Estimates and Forecasts 2020-2031
2.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sacubitril Valsartan Sodium Drugs Sales Estimates and Forecasts 2020-2031
2.4 Global Sacubitril Valsartan Sodium Drugs Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sacubitril Valsartan Sodium Drugs Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Tablets Market Size by Manufacturers
3.5.2 Oral Pellets Market Size by Manufacturers
3.6 Global Sacubitril Valsartan Sodium Drugs Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sacubitril Valsartan Sodium Drugs Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sacubitril Valsartan Sodium Drugs Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sacubitril Valsartan Sodium Drugs Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sacubitril Valsartan Sodium Drugs Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)
6.4 North America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sacubitril Valsartan Sodium Drugs Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)
7.4 Europe Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sacubitril Valsartan Sodium Drugs Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sacubitril Valsartan Sodium Drugs Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sacubitril Valsartan Sodium Drugs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sacubitril Valsartan Sodium Drugs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview
11.1.3 Novartis Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.1.4 Novartis Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Novartis Sacubitril Valsartan Sodium Drugs Sales by Product in 2024
11.1.6 Novartis Sacubitril Valsartan Sodium Drugs Sales by Application in 2024
11.1.7 Novartis Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024
11.1.8 Novartis Sacubitril Valsartan Sodium Drugs SWOT Analysis
11.1.9 Novartis Recent Developments
11.2 MSN
11.2.1 MSN Corporation Information
11.2.2 MSN Business Overview
11.2.3 MSN Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.2.4 MSN Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 MSN Sacubitril Valsartan Sodium Drugs Sales by Product in 2024
11.2.6 MSN Sacubitril Valsartan Sodium Drugs Sales by Application in 2024
11.2.7 MSN Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024
11.2.8 MSN Sacubitril Valsartan Sodium Drugs SWOT Analysis
11.2.9 MSN Recent Developments
11.3 Arlak Corazon
11.3.1 Arlak Corazon Corporation Information
11.3.2 Arlak Corazon Business Overview
11.3.3 Arlak Corazon Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.3.4 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Product in 2024
11.3.6 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Application in 2024
11.3.7 Arlak Corazon Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024
11.3.8 Arlak Corazon Sacubitril Valsartan Sodium Drugs SWOT Analysis
11.3.9 Arlak Corazon Recent Developments
11.4 Sanof
11.4.1 Sanof Corporation Information
11.4.2 Sanof Business Overview
11.4.3 Sanof Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.4.4 Sanof Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sanof Sacubitril Valsartan Sodium Drugs Sales by Product in 2024
11.4.6 Sanof Sacubitril Valsartan Sodium Drugs Sales by Application in 2024
11.4.7 Sanof Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024
11.4.8 Sanof Sacubitril Valsartan Sodium Drugs SWOT Analysis
11.4.9 Sanof Recent Developments
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Business Overview
11.5.3 Cipla Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.5.4 Cipla Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Cipla Sacubitril Valsartan Sodium Drugs Sales by Product in 2024
11.5.6 Cipla Sacubitril Valsartan Sodium Drugs Sales by Application in 2024
11.5.7 Cipla Sacubitril Valsartan Sodium Drugs Sales by Geographic Area in 2024
11.5.8 Cipla Sacubitril Valsartan Sodium Drugs SWOT Analysis
11.5.9 Cipla Recent Developments
11.6 Farmanova pharma
11.6.1 Farmanova pharma Corporation Information
11.6.2 Farmanova pharma Business Overview
11.6.3 Farmanova pharma Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.6.4 Farmanova pharma Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Farmanova pharma Recent Developments
11.7 General Pharmaceuticals
11.7.1 General Pharmaceuticals Corporation Information
11.7.2 General Pharmaceuticals Business Overview
11.7.3 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.7.4 General Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 General Pharmaceuticals Recent Developments
11.8 Addii Biotech
11.8.1 Addii Biotech Corporation Information
11.8.2 Addii Biotech Business Overview
11.8.3 Addii Biotech Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.8.4 Addii Biotech Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Addii Biotech Recent Developments
11.9 Qilu Pharmaceutical
11.9.1 Qilu Pharmaceutical Corporation Information
11.9.2 Qilu Pharmaceutical Business Overview
11.9.3 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.9.4 Qilu Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Qilu Pharmaceutical Recent Developments
11.10 Chengdu Brilliant Pharmaceutical
11.10.1 Chengdu Brilliant Pharmaceutical Corporation Information
11.10.2 Chengdu Brilliant Pharmaceutical Business Overview
11.10.3 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.10.4 Chengdu Brilliant Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Chengdu Brilliant Pharmaceutical Recent Developments
11.11 TC Pharmaceuticals (Jiangsu)
11.11.1 TC Pharmaceuticals (Jiangsu) Corporation Information
11.11.2 TC Pharmaceuticals (Jiangsu) Business Overview
11.11.3 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.11.4 TC Pharmaceuticals (Jiangsu) Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 TC Pharmaceuticals (Jiangsu) Recent Developments
11.12 Chia Tai Tianqing Pharmaceutical
11.12.1 Chia Tai Tianqing Pharmaceutical Corporation Information
11.12.2 Chia Tai Tianqing Pharmaceutical Business Overview
11.12.3 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.12.4 Chia Tai Tianqing Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments
11.13 CSPC Ouyi Pharmaceutical
11.13.1 CSPC Ouyi Pharmaceutical Corporation Information
11.13.2 CSPC Ouyi Pharmaceutical Business Overview
11.13.3 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.13.4 CSPC Ouyi Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 CSPC Ouyi Pharmaceutical Recent Developments
11.14 Changzhou Pharmaceutical Factory
11.14.1 Changzhou Pharmaceutical Factory Corporation Information
11.14.2 Changzhou Pharmaceutical Factory Business Overview
11.14.3 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.14.4 Changzhou Pharmaceutical Factory Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Changzhou Pharmaceutical Factory Recent Developments
11.15 Zhejiang Nord Pharmaceutical
11.15.1 Zhejiang Nord Pharmaceutical Corporation Information
11.15.2 Zhejiang Nord Pharmaceutical Business Overview
11.15.3 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.15.4 Zhejiang Nord Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Zhejiang Nord Pharmaceutical Recent Developments
11.16 Kelun Pharmaceutical
11.16.1 Kelun Pharmaceutical Corporation Information
11.16.2 Kelun Pharmaceutical Business Overview
11.16.3 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.16.4 Kelun Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Kelun Pharmaceutical Recent Developments
11.17 Sihuan Pharmaceutical
11.17.1 Sihuan Pharmaceutical Corporation Information
11.17.2 Sihuan Pharmaceutical Business Overview
11.17.3 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.17.4 Sihuan Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Sihuan Pharmaceutical Recent Developments
11.18 Sino Therapeutics
11.18.1 Sino Therapeutics Corporation Information
11.18.2 Sino Therapeutics Business Overview
11.18.3 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.18.4 Sino Therapeutics Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Sino Therapeutics Recent Developments
11.19 Zhejiang AngLiKang Pharmaceutical
11.19.1 Zhejiang AngLiKang Pharmaceutical Corporation Information
11.19.2 Zhejiang AngLiKang Pharmaceutical Business Overview
11.19.3 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.19.4 Zhejiang AngLiKang Pharmaceutical Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Zhejiang AngLiKang Pharmaceutical Recent Developments
11.20 Shenzhen Salubris Pharmaceuticals
11.20.1 Shenzhen Salubris Pharmaceuticals Corporation Information
11.20.2 Shenzhen Salubris Pharmaceuticals Business Overview
11.20.3 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Product Models, Descriptions and Specifications
11.20.4 Shenzhen Salubris Pharmaceuticals Sacubitril Valsartan Sodium Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Shenzhen Salubris Pharmaceuticals Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sacubitril Valsartan Sodium Drugs Industry Chain
12.2 Sacubitril Valsartan Sodium Drugs Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sacubitril Valsartan Sodium Drugs Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sacubitril Valsartan Sodium Drugs Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sacubitril Valsartan Sodium Drugs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sacubitril Valsartan Sodium Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sacubitril Valsartan Sodium Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Sacubitril Valsartan Sodium Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2020-2025) & (K Units)
Table 8. Global Sacubitril Valsartan Sodium Drugs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Sacubitril Valsartan Sodium Drugs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Sacubitril Valsartan Sodium Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global Sacubitril Valsartan Sodium Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Sacubitril Valsartan Sodium Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacubitril Valsartan Sodium Drugs as of 2024)
Table 16. Global Sacubitril Valsartan Sodium Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Sacubitril Valsartan Sodium Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Sacubitril Valsartan Sodium Drugs Manufacturing Base and Headquarters
Table 19. Global Sacubitril Valsartan Sodium Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2020-2025) & (K Units)
Table 23. Global Sacubitril Valsartan Sodium Drugs Sales by Type (2026-2031) & (K Units)
Table 24. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Sacubitril Valsartan Sodium Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Sacubitril Valsartan Sodium Drugs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2020-2025) & (K Units)
Table 29. Global Sacubitril Valsartan Sodium Drugs Sales by Application (2026-2031) & (K Units)
Table 30. Sacubitril Valsartan Sodium Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Sacubitril Valsartan Sodium Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Sacubitril Valsartan Sodium Drugs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers
Table 37. North America Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers
Table 40. Europe Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Sacubitril Valsartan Sodium Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Sacubitril Valsartan Sodium Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Sacubitril Valsartan Sodium Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Novartis Corporation Information
Table 51. Novartis Description and Major Businesses
Table 52. Novartis Product Models, Descriptions and Specifications
Table 53. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Novartis Sales Value Proportion by Product in 2024
Table 55. Novartis Sales Value Proportion by Application in 2024
Table 56. Novartis Sales Value Proportion by Geographic Area in 2024
Table 57. Novartis Sacubitril Valsartan Sodium Drugs SWOT Analysis
Table 58. Novartis Recent Developments
Table 59. MSN Corporation Information
Table 60. MSN Description and Major Businesses
Table 61. MSN Product Models, Descriptions and Specifications
Table 62. MSN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. MSN Sales Value Proportion by Product in 2024
Table 64. MSN Sales Value Proportion by Application in 2024
Table 65. MSN Sales Value Proportion by Geographic Area in 2024
Table 66. MSN Sacubitril Valsartan Sodium Drugs SWOT Analysis
Table 67. MSN Recent Developments
Table 68. Arlak Corazon Corporation Information
Table 69. Arlak Corazon Description and Major Businesses
Table 70. Arlak Corazon Product Models, Descriptions and Specifications
Table 71. Arlak Corazon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Arlak Corazon Sales Value Proportion by Product in 2024
Table 73. Arlak Corazon Sales Value Proportion by Application in 2024
Table 74. Arlak Corazon Sales Value Proportion by Geographic Area in 2024
Table 75. Arlak Corazon Sacubitril Valsartan Sodium Drugs SWOT Analysis
Table 76. Arlak Corazon Recent Developments
Table 77. Sanof Corporation Information
Table 78. Sanof Description and Major Businesses
Table 79. Sanof Product Models, Descriptions and Specifications
Table 80. Sanof Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sanof Sales Value Proportion by Product in 2024
Table 82. Sanof Sales Value Proportion by Application in 2024
Table 83. Sanof Sales Value Proportion by Geographic Area in 2024
Table 84. Sanof Sacubitril Valsartan Sodium Drugs SWOT Analysis
Table 85. Sanof Recent Developments
Table 86. Cipla Corporation Information
Table 87. Cipla Description and Major Businesses
Table 88. Cipla Product Models, Descriptions and Specifications
Table 89. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Cipla Sales Value Proportion by Product in 2024
Table 91. Cipla Sales Value Proportion by Application in 2024
Table 92. Cipla Sales Value Proportion by Geographic Area in 2024
Table 93. Cipla Sacubitril Valsartan Sodium Drugs SWOT Analysis
Table 94. Cipla Recent Developments
Table 95. Farmanova pharma Corporation Information
Table 96. Farmanova pharma Description and Major Businesses
Table 97. Farmanova pharma Product Models, Descriptions and Specifications
Table 98. Farmanova pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Farmanova pharma Recent Developments
Table 100. General Pharmaceuticals Corporation Information
Table 101. General Pharmaceuticals Description and Major Businesses
Table 102. General Pharmaceuticals Product Models, Descriptions and Specifications
Table 103. General Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. General Pharmaceuticals Recent Developments
Table 105. Addii Biotech Corporation Information
Table 106. Addii Biotech Description and Major Businesses
Table 107. Addii Biotech Product Models, Descriptions and Specifications
Table 108. Addii Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Addii Biotech Recent Developments
Table 110. Qilu Pharmaceutical Corporation Information
Table 111. Qilu Pharmaceutical Description and Major Businesses
Table 112. Qilu Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Qilu Pharmaceutical Recent Developments
Table 115. Chengdu Brilliant Pharmaceutical Corporation Information
Table 116. Chengdu Brilliant Pharmaceutical Description and Major Businesses
Table 117. Chengdu Brilliant Pharmaceutical Product Models, Descriptions and Specifications
Table 118. Chengdu Brilliant Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Chengdu Brilliant Pharmaceutical Recent Developments
Table 120. TC Pharmaceuticals (Jiangsu) Corporation Information
Table 121. TC Pharmaceuticals (Jiangsu) Description and Major Businesses
Table 122. TC Pharmaceuticals (Jiangsu) Product Models, Descriptions and Specifications
Table 123. TC Pharmaceuticals (Jiangsu) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. TC Pharmaceuticals (Jiangsu) Recent Developments
Table 125. Chia Tai Tianqing Pharmaceutical Corporation Information
Table 126. Chia Tai Tianqing Pharmaceutical Description and Major Businesses
Table 127. Chia Tai Tianqing Pharmaceutical Product Models, Descriptions and Specifications
Table 128. Chia Tai Tianqing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments
Table 130. CSPC Ouyi Pharmaceutical Corporation Information
Table 131. CSPC Ouyi Pharmaceutical Description and Major Businesses
Table 132. CSPC Ouyi Pharmaceutical Product Models, Descriptions and Specifications
Table 133. CSPC Ouyi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. CSPC Ouyi Pharmaceutical Recent Developments
Table 135. Changzhou Pharmaceutical Factory Corporation Information
Table 136. Changzhou Pharmaceutical Factory Description and Major Businesses
Table 137. Changzhou Pharmaceutical Factory Product Models, Descriptions and Specifications
Table 138. Changzhou Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Changzhou Pharmaceutical Factory Recent Developments
Table 140. Zhejiang Nord Pharmaceutical Corporation Information
Table 141. Zhejiang Nord Pharmaceutical Description and Major Businesses
Table 142. Zhejiang Nord Pharmaceutical Product Models, Descriptions and Specifications
Table 143. Zhejiang Nord Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Zhejiang Nord Pharmaceutical Recent Developments
Table 145. Kelun Pharmaceutical Corporation Information
Table 146. Kelun Pharmaceutical Description and Major Businesses
Table 147. Kelun Pharmaceutical Product Models, Descriptions and Specifications
Table 148. Kelun Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Kelun Pharmaceutical Recent Developments
Table 150. Sihuan Pharmaceutical Corporation Information
Table 151. Sihuan Pharmaceutical Description and Major Businesses
Table 152. Sihuan Pharmaceutical Product Models, Descriptions and Specifications
Table 153. Sihuan Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Sihuan Pharmaceutical Recent Developments
Table 155. Sino Therapeutics Corporation Information
Table 156. Sino Therapeutics Description and Major Businesses
Table 157. Sino Therapeutics Product Models, Descriptions and Specifications
Table 158. Sino Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Sino Therapeutics Recent Developments
Table 160. Zhejiang AngLiKang Pharmaceutical Corporation Information
Table 161. Zhejiang AngLiKang Pharmaceutical Description and Major Businesses
Table 162. Zhejiang AngLiKang Pharmaceutical Product Models, Descriptions and Specifications
Table 163. Zhejiang AngLiKang Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Zhejiang AngLiKang Pharmaceutical Recent Developments
Table 165. Shenzhen Salubris Pharmaceuticals Corporation Information
Table 166. Shenzhen Salubris Pharmaceuticals Description and Major Businesses
Table 167. Shenzhen Salubris Pharmaceuticals Product Models, Descriptions and Specifications
Table 168. Shenzhen Salubris Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 170. Key Raw Materials Distribution
Table 171. Raw Materials Key Suppliers
Table 172. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 173. Milestones in Production Technology Evolution
Table 174. Distributors List
Table 175. Market Trends and Market Evolution
Table 176. Market Drivers and Opportunities
Table 177. Market Challenges, Risks, and Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources


List of Figures
Figure 1. Sacubitril Valsartan Sodium Drugs Product Picture
Figure 2. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Tablets Product Picture
Figure 4. Oral Pellets Product Picture
Figure 5. Global Sacubitril Valsartan Sodium Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital and Clinic
Figure 7. Retail Pharmacies
Figure 8. Other
Figure 9. Sacubitril Valsartan Sodium Drugs Report Years Considered
Figure 10. Global Sacubitril Valsartan Sodium Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 12. Global Sacubitril Valsartan Sodium Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Region (2020-2031)
Figure 14. Global Sacubitril Valsartan Sodium Drugs Sales (2020-2031) & (K Units)
Figure 15. Global Sacubitril Valsartan Sodium Drugs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Volume Market Share in 2024
Figure 18. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Tablets Revenue Market Share by Manufacturer in 2024
Figure 21. Oral Pellets Revenue Market Share by Manufacturer in 2024
Figure 22. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Type (2020-2031)
Figure 23. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Type (2020-2031)
Figure 24. Global Sacubitril Valsartan Sodium Drugs Sales Market Share by Application (2020-2031)
Figure 25. Global Sacubitril Valsartan Sodium Drugs Revenue Market Share by Application (2020-2031)
Figure 26. North America Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)
Figure 27. North America Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024
Figure 29. North America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024
Figure 39. Europe Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 44. France Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 59. India Sacubitril Valsartan Sodium Drugs Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Sacubitril Valsartan Sodium Drugs Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Sacubitril Valsartan Sodium Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Sacubitril Valsartan Sodium Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Sacubitril Valsartan Sodium Drugs Revenue (2020-2025) & (US$ Million)
Figure 80. Sacubitril Valsartan Sodium Drugs Industry Chain Mapping
Figure 81. Regional Sacubitril Valsartan Sodium Drugs Manufacturing Base Distribution (%)
Figure 82. Global Sacubitril Valsartan Sodium Drugs Production Market Share by Region (2020-2031)
Figure 83. Sacubitril Valsartan Sodium Drugs Production Process
Figure 84. Regional Sacubitril Valsartan Sodium Drugs Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit